346 related articles for article (PubMed ID: 31380245)
1. Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting.
Garg U; Chauhan S; Nagaich U; Jain N
Adv Pharm Bull; 2019 Jun; 9(2):195-204. PubMed ID: 31380245
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-Based Nanoparticles Against Viral Infections.
Boroumand H; Badie F; Mazaheri S; Seyedi ZS; Nahand JS; Nejati M; Baghi HB; Abbasi-Kolli M; Badehnoosh B; Ghandali M; Hamblin MR; Mirzaei H
Front Cell Infect Microbiol; 2021; 11():643953. PubMed ID: 33816349
[TBL] [Abstract][Full Text] [Related]
3. A Review of the Preparation, Characterization, and Applications of Chitosan Nanoparticles in Nanomedicine.
Jha R; Mayanovic RA
Nanomaterials (Basel); 2023 Apr; 13(8):. PubMed ID: 37110887
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research.
Naskar S; Koutsu K; Sharma S
J Drug Target; 2019 Apr; 27(4):379-393. PubMed ID: 30103626
[TBL] [Abstract][Full Text] [Related]
5. Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article.
Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Bustanji Y; Hamad I
Curr Drug Targets; 2020; 21(15):1613-1624. PubMed ID: 32651965
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery.
Lin Y; Sun B; Jin Z; Zhao K
ACS Appl Mater Interfaces; 2022 Nov; 14(47):52691-52701. PubMed ID: 36382954
[TBL] [Abstract][Full Text] [Related]
7. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
[TBL] [Abstract][Full Text] [Related]
8. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
9. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
Moraru C; Mincea M; Menghiu G; Ostafe V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
[TBL] [Abstract][Full Text] [Related]
11. Chitosan nanoparticles: a promising system in novel drug delivery.
Nagpal K; Singh SK; Mishra DN
Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1423-30. PubMed ID: 21048331
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives.
Karayianni M; Sentoukas T; Skandalis A; Pippa N; Pispas S
Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514036
[TBL] [Abstract][Full Text] [Related]
13. Advances in Chitosan-Based Nanoparticles for Drug Delivery.
Mikušová V; Mikuš P
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502560
[TBL] [Abstract][Full Text] [Related]
14. Catechol-modified chitosan/hyaluronic acid nanoparticles as a new avenue for local delivery of doxorubicin to oral cancer cells.
Pornpitchanarong C; Rojanarata T; Opanasopit P; Ngawhirunpat T; Patrojanasophon P
Colloids Surf B Biointerfaces; 2020 Dec; 196():111279. PubMed ID: 32750605
[TBL] [Abstract][Full Text] [Related]
15. Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications.
Wang F; Yang S; Yuan J; Gao Q; Huang C
J Biomater Appl; 2016 Jul; 31(1):3-12. PubMed ID: 27164869
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.
Islam N; Ferro V
Nanoscale; 2016 Aug; 8(30):14341-58. PubMed ID: 27439116
[TBL] [Abstract][Full Text] [Related]
17. Ionically Cross-Linked Chitosan Nanoparticles for Sustained Delivery of Docetaxel: Fabrication, Post-Formulation and Acute Oral Toxicity Evaluation.
Mahmood MA; Madni A; Rehman M; Rahim MA; Jabar A
Int J Nanomedicine; 2019; 14():10035-10046. PubMed ID: 31908458
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-Based Nanoparticles for Targeted Nasal Galantamine Delivery as a Promising Tool in Alzheimer's Disease Therapy.
Georgieva D; Nikolova D; Vassileva E; Kostova B
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986689
[TBL] [Abstract][Full Text] [Related]
19. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.
Asal HA; Shoueir KR; El-Hagrasy MA; Toson EA
Int J Biol Macromol; 2022 Jun; 209(Pt B):2188-2196. PubMed ID: 35504421
[TBL] [Abstract][Full Text] [Related]
20. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.
Liu S; Ho PC
J Pharm Pharmacol; 2017 Nov; 69(11):1495-1501. PubMed ID: 28809432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
